TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Divanmedicin AB
Closing information (x1000 EUR)
Closing information | 2023/08 | 2022/08 | 2021/08 |
Turnover |
227
|
247
|
205 |
Financial expenses |
2
|
7
|
2 |
Earnings before taxes |
54
|
47
|
31 |
EBITDA |
39
|
38
|
29 |
Total assets |
468
|
444
|
487 |
Current assets |
26
|
66
|
80 |
Current liabilities |
59
|
60
|
66 |
Equity capital |
368
|
373
|
383 |
- share capital |
8
|
9
|
10 |
Employees (average) |
2
![]() |
2
|
1 |
Financial ratios
Fiscal year | 2023/08 | 2022/08 | 2021/08 |
Solvency |
78.6%
|
84.0%
|
78.6% |
Turnover per employee |
114
|
124
|
205 |
Profit as a percentage of turnover |
23.8%
|
19.0%
|
15.1% |
Return on assets (ROA) |
12.0%
|
12.2%
|
6.8% |
Current ratio |
44.1%
|
110.0%
|
121.2% |
Return on equity (ROE) |
14.7%
|
12.6%
|
8.1% |
Change turnover |
5
|
52
|
49 |
Change turnover % |
2%
|
27%
|
32% |
Chg. No. of employees |
0
|
1
|
0 |
Chg. No. of employees % |
0%
|
100%
|
0% |
Total value of public sale
Fiscal year | 2023/08 | 2022/08 | 2021/08 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.